News
Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...
Pfizer will continue operating in Lee County after consolidating facilities. The move comes 18 months after Pfizer confirmed ...
Unlike Trump's first term, his proposed "most favored nation" policy, tying U.S. drug prices to the lowest prices paid by ...
Donald Trump has signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines ...
Health policy experts said it is still unclear how much prices will go down, which medicines will be impacted and whether the ...
An executive order the president signed Monday could reduce prices, but some warn it could backfire and raise costs.
US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...
U.S. President Donald Trump holds an executive order on prescription drug pricing next to U.S. Health and Human Services (HHS ...
President Donald Trump is attempting to slash drug prices for Americans by more closely aligning their costs to lower prices paid abroad, renewing and expanding upon a failed push from his first term.
Asian pharma stocks tumble as Trump plans to slash U.S. drug prices by up to 80%. Discover impacts on major firms like Chugai ...
The order is a blow to the pharmaceutical industry, which is already bracing for Trump's planned tariffs on prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results